Publication | Open Access

The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study

Cancer ImmunosurveillancePrognostic ImpactMedicineImmune Checkpoint InhibitorsImmunologyImmune Checkpoint InhibitorBronchial NeoplasmMulticenter Retrospective StudyCancer TreatmentImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentLung Cancer